Form 4: UNITED THERAPEUTICS CEO Sells Shares
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on August 20, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $135.42 ($1,286,490) on August 20, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 976 Common Stock at $518.45 ($506,006) on August 20, 2026; holds 332,967 after (Indirect).
- Open-market sale: disposed of 1,504 Common Stock at $519.51 ($781,344) on August 20, 2026; holds 331,463 after (Indirect).
- Open-market sale: disposed of 2,357 Common Stock at $520.46 ($1,226,713) on August 20, 2026; holds 329,106 after (Indirect).
- Open-market sale: disposed of 2,470 Common Stock at $521.39 ($1,287,843) on August 20, 2026; holds 326,636 after (Indirect).
- Open-market sale: disposed of 960 Common Stock at $522.37 ($501,477) on August 20, 2026; holds 325,676 after (Indirect).
- Open-market sale: disposed of 800 Common Stock at $523.26 ($418,607) on August 20, 2026; holds 324,876 after (Indirect).
- Open-market sale: disposed of 240 Common Stock at $525.10 ($126,023) on August 20, 2026; holds 324,636 after (Indirect).
- Open-market sale: disposed of 193 Common Stock at $526.97 ($101,705) on August 20, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on August 20, 2026; holds 94,410 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $4,949,717 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-20 | Option exercise/conversion | Common Stock | 9,500 | $135 | $1.3M | 333,943 |
| 2026-08-20 | Open-market sale | Common Stock | 976 | $518 | $506.0K | 332,967 |
| 2026-08-20 | Open-market sale | Common Stock | 1,504 | $520 | $781.3K | 331,463 |
| 2026-08-20 | Open-market sale | Common Stock | 2,357 | $520 | $1.2M | 329,106 |
| 2026-08-20 | Open-market sale | Common Stock | 2,470 | $521 | $1.3M | 326,636 |
| 2026-08-20 | Open-market sale | Common Stock | 960 | $522 | $501.5K | 325,676 |
| 2026-08-20 | Open-market sale | Common Stock | 800 | $523 | $418.6K | 324,876 |
| 2026-08-20 | Open-market sale | Common Stock | 240 | $525 | $126.0K | 324,636 |
| 2026-08-20 | Open-market sale | Common Stock | 193 | $527 | $101.7K | 324,443 |
| 2026-08-20 | Option exercise/conversion | Stock Option | 9,500 | — | — | 94,410 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-20 | Option exercise/conversion (9,500 shares) |
| 2026-08-20 | Open-market sale (976 shares) |
| 2026-08-20 | Open-market sale (1,504 shares) |
| 2026-08-20 | Open-market sale (2,357 shares) |
| 2026-08-20 | Open-market sale (2,470 shares) |
| 2026-08-20 | Open-market sale (960 shares) |
| 2026-08-20 | Open-market sale (800 shares) |
| 2026-08-20 | Open-market sale (240 shares) |
| 2026-08-20 | Open-market sale (193 shares) |
| 2026-08-20 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.